2 Classes Certified In Drug Pricing Suit

In a blow to AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Co., a federal judge has given the green light to two national classes in the multidistrict litigation over average wholesale drug...

Already a subscriber? Click here to view full article